A pilot multicenter randomized controlled trial on individualized blood pressure targets versus standard care among critically ill patients with shock

Abstract Background Minimizing relative hypotension, or mean arterial pressure (MAP) deficit, by targeting patients’ own pre-illness MAP (individualized MAP) during vasopressor therapy is a potential strategy to improve outcomes among ICU patients with shock. We conducted a prospective, open label,...

Full description

Saved in:
Bibliographic Details
Main Authors: Rakshit Panwar, Bairbre McNicholas, Ciprian Nita, Alison Gibberd, Amber-Louise Poulter, Marcia Tauares, Lauren Ferguson
Format: Article
Language:English
Published: BMC 2025-05-01
Series:Journal of Intensive Care
Subjects:
Online Access:https://doi.org/10.1186/s40560-025-00798-8
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849704141883965440
author Rakshit Panwar
Bairbre McNicholas
Ciprian Nita
Alison Gibberd
Amber-Louise Poulter
Marcia Tauares
Lauren Ferguson
author_facet Rakshit Panwar
Bairbre McNicholas
Ciprian Nita
Alison Gibberd
Amber-Louise Poulter
Marcia Tauares
Lauren Ferguson
author_sort Rakshit Panwar
collection DOAJ
description Abstract Background Minimizing relative hypotension, or mean arterial pressure (MAP) deficit, by targeting patients’ own pre-illness MAP (individualized MAP) during vasopressor therapy is a potential strategy to improve outcomes among ICU patients with shock. We conducted a prospective, open label, parallel-group, pilot RCT to assess feasibility and safety of this intervention compared to standard care. Methods Thirty-seven eligible patients, aged 40 years or older and receiving vasopressor support for shock, were randomly allocated to individualized MAP target (N = 17) or standard MAP target (N = 20) at two multidisciplinary ICUs in Australia and Ireland. Pre-specified endpoints were time-weighted average MAP-deficit (i.e., percentage difference between patients’ pre-illness MAP and achieved-MAP), percentage time spent with > 20% MAP-deficit, major adverse kidney events (MAKE-14), 14-day and 90-day all-cause mortality, and cardiovascular adverse events within 28 days of randomization. All comparisons of efficacy outcomes were exploratory. Results The median MAP-deficit and percentage time with > 20% MAP-deficit with individualized MAP vs. standard MAP were 7% [interquartile range: 2–16] vs. 18% [9–23] (p = 0.048), and 8% [0–43] vs. 53% [14–75] (p = 0.03), respectively. MAKE-14 (2/17 (12%) vs. 4/20 (20%), p = 0.67), 14-day mortality (1/17 (6%) vs. 3/20 (15%), p = 0.61), 90-day mortality (2/17 (12%) vs. 4/20 (20%), p = 0.67) and cardiovascular adverse events were similar for both groups. Conclusions This pilot RCT demonstrated that an individualized MAP target strategy was feasible to implement. No adverse safety signals were evident. These data and study procedures helped inform the design of a definitive RCT on the question of individualized MAP targets among critically ill patients with shock. Study registration: ACTRN12618000571279.
format Article
id doaj-art-d7283b91db674dc2a83fbe1cac23b890
institution DOAJ
issn 2052-0492
language English
publishDate 2025-05-01
publisher BMC
record_format Article
series Journal of Intensive Care
spelling doaj-art-d7283b91db674dc2a83fbe1cac23b8902025-08-20T03:16:52ZengBMCJournal of Intensive Care2052-04922025-05-0113111110.1186/s40560-025-00798-8A pilot multicenter randomized controlled trial on individualized blood pressure targets versus standard care among critically ill patients with shockRakshit Panwar0Bairbre McNicholas1Ciprian Nita2Alison Gibberd3Amber-Louise Poulter4Marcia Tauares5Lauren Ferguson6Intensive Care Unit, John Hunter HospitalIntensive Care Unit, Galway University HospitalIntensive Care Unit, Galway University HospitalHunter Medical Research InstituteIntensive Care Unit, John Hunter HospitalIntensive Care Unit, Galway University HospitalIntensive Care Unit, Galway University HospitalAbstract Background Minimizing relative hypotension, or mean arterial pressure (MAP) deficit, by targeting patients’ own pre-illness MAP (individualized MAP) during vasopressor therapy is a potential strategy to improve outcomes among ICU patients with shock. We conducted a prospective, open label, parallel-group, pilot RCT to assess feasibility and safety of this intervention compared to standard care. Methods Thirty-seven eligible patients, aged 40 years or older and receiving vasopressor support for shock, were randomly allocated to individualized MAP target (N = 17) or standard MAP target (N = 20) at two multidisciplinary ICUs in Australia and Ireland. Pre-specified endpoints were time-weighted average MAP-deficit (i.e., percentage difference between patients’ pre-illness MAP and achieved-MAP), percentage time spent with > 20% MAP-deficit, major adverse kidney events (MAKE-14), 14-day and 90-day all-cause mortality, and cardiovascular adverse events within 28 days of randomization. All comparisons of efficacy outcomes were exploratory. Results The median MAP-deficit and percentage time with > 20% MAP-deficit with individualized MAP vs. standard MAP were 7% [interquartile range: 2–16] vs. 18% [9–23] (p = 0.048), and 8% [0–43] vs. 53% [14–75] (p = 0.03), respectively. MAKE-14 (2/17 (12%) vs. 4/20 (20%), p = 0.67), 14-day mortality (1/17 (6%) vs. 3/20 (15%), p = 0.61), 90-day mortality (2/17 (12%) vs. 4/20 (20%), p = 0.67) and cardiovascular adverse events were similar for both groups. Conclusions This pilot RCT demonstrated that an individualized MAP target strategy was feasible to implement. No adverse safety signals were evident. These data and study procedures helped inform the design of a definitive RCT on the question of individualized MAP targets among critically ill patients with shock. Study registration: ACTRN12618000571279.https://doi.org/10.1186/s40560-025-00798-8Blood pressure targetMean arterial pressure deficitRelative hypotensionIntensive careShock
spellingShingle Rakshit Panwar
Bairbre McNicholas
Ciprian Nita
Alison Gibberd
Amber-Louise Poulter
Marcia Tauares
Lauren Ferguson
A pilot multicenter randomized controlled trial on individualized blood pressure targets versus standard care among critically ill patients with shock
Journal of Intensive Care
Blood pressure target
Mean arterial pressure deficit
Relative hypotension
Intensive care
Shock
title A pilot multicenter randomized controlled trial on individualized blood pressure targets versus standard care among critically ill patients with shock
title_full A pilot multicenter randomized controlled trial on individualized blood pressure targets versus standard care among critically ill patients with shock
title_fullStr A pilot multicenter randomized controlled trial on individualized blood pressure targets versus standard care among critically ill patients with shock
title_full_unstemmed A pilot multicenter randomized controlled trial on individualized blood pressure targets versus standard care among critically ill patients with shock
title_short A pilot multicenter randomized controlled trial on individualized blood pressure targets versus standard care among critically ill patients with shock
title_sort pilot multicenter randomized controlled trial on individualized blood pressure targets versus standard care among critically ill patients with shock
topic Blood pressure target
Mean arterial pressure deficit
Relative hypotension
Intensive care
Shock
url https://doi.org/10.1186/s40560-025-00798-8
work_keys_str_mv AT rakshitpanwar apilotmulticenterrandomizedcontrolledtrialonindividualizedbloodpressuretargetsversusstandardcareamongcriticallyillpatientswithshock
AT bairbremcnicholas apilotmulticenterrandomizedcontrolledtrialonindividualizedbloodpressuretargetsversusstandardcareamongcriticallyillpatientswithshock
AT cipriannita apilotmulticenterrandomizedcontrolledtrialonindividualizedbloodpressuretargetsversusstandardcareamongcriticallyillpatientswithshock
AT alisongibberd apilotmulticenterrandomizedcontrolledtrialonindividualizedbloodpressuretargetsversusstandardcareamongcriticallyillpatientswithshock
AT amberlouisepoulter apilotmulticenterrandomizedcontrolledtrialonindividualizedbloodpressuretargetsversusstandardcareamongcriticallyillpatientswithshock
AT marciatauares apilotmulticenterrandomizedcontrolledtrialonindividualizedbloodpressuretargetsversusstandardcareamongcriticallyillpatientswithshock
AT laurenferguson apilotmulticenterrandomizedcontrolledtrialonindividualizedbloodpressuretargetsversusstandardcareamongcriticallyillpatientswithshock
AT rakshitpanwar pilotmulticenterrandomizedcontrolledtrialonindividualizedbloodpressuretargetsversusstandardcareamongcriticallyillpatientswithshock
AT bairbremcnicholas pilotmulticenterrandomizedcontrolledtrialonindividualizedbloodpressuretargetsversusstandardcareamongcriticallyillpatientswithshock
AT cipriannita pilotmulticenterrandomizedcontrolledtrialonindividualizedbloodpressuretargetsversusstandardcareamongcriticallyillpatientswithshock
AT alisongibberd pilotmulticenterrandomizedcontrolledtrialonindividualizedbloodpressuretargetsversusstandardcareamongcriticallyillpatientswithshock
AT amberlouisepoulter pilotmulticenterrandomizedcontrolledtrialonindividualizedbloodpressuretargetsversusstandardcareamongcriticallyillpatientswithshock
AT marciatauares pilotmulticenterrandomizedcontrolledtrialonindividualizedbloodpressuretargetsversusstandardcareamongcriticallyillpatientswithshock
AT laurenferguson pilotmulticenterrandomizedcontrolledtrialonindividualizedbloodpressuretargetsversusstandardcareamongcriticallyillpatientswithshock